Global In Silico Clinical Trials Market Size, Share, Trend and Forecast 2026 | TechSci Research

1
2016 2026
GLOBAL IN SILICO CLINICAL TRIALS MARKET FORECAST
OPPORTUNITIES
2

• Scope of Report
• Product of Interest (POI) In Silico Clinical
  Trials

An in silico clinical trial is an individualised
computer simulation used in the development or
regulatory evaluation of a medicinal product,
device, or intervention. While completely
simulated clinical trials are not feasible with
current technology and understanding of biology,
its development would be expected to have major
benefits over current in vivo clinical trials,
and research on it is being pursued.
Market Segmentation
INDUSTRY

• Medical Devices
• Pharmaceutical

THERAPEUTIC AREA

• Oncology
• Infectious Disease
• Hematology
• Cardiology
• Dermatology
• Neurology
• Diabetes
• Others

3

• Table of Contents

S. No. Contents Contents Contents Page No.
1. Product Overview (Definition of product and major terminologies used in the report) Product Overview (Definition of product and major terminologies used in the report) Product Overview (Definition of product and major terminologies used in the report)
2. Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys) Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys) Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys)
3. Impact of COVID-19 on Global In Silico Clinical Trials Market Impact of COVID-19 on Global In Silico Clinical Trials Market Impact of COVID-19 on Global In Silico Clinical Trials Market
4. Executive Summary (This chapter covers summary of the complete study.) Executive Summary (This chapter covers summary of the complete study.) Executive Summary (This chapter covers summary of the complete study.)
5. Voice of Customer Voice of Customer Voice of Customer
5.1. Product/Service Awareness Product/Service Awareness
5.2. Brand Awareness Brand Awareness
5.3. Benefits of Switching to In Silico Clinical Trials Benefits of Switching to In Silico Clinical Trials
6. Global In Silico Clinical Trials Market Outlook, 2016-2026F (This chapter includes a brief overview of the product of interest market such as total markets growth rate, expected growth rate, key growth levers, leading region, top grossing product types, etc. It includes more of a qualitative information about the market.) Global In Silico Clinical Trials Market Outlook, 2016-2026F (This chapter includes a brief overview of the product of interest market such as total markets growth rate, expected growth rate, key growth levers, leading region, top grossing product types, etc. It includes more of a qualitative information about the market.) Global In Silico Clinical Trials Market Outlook, 2016-2026F (This chapter includes a brief overview of the product of interest market such as total markets growth rate, expected growth rate, key growth levers, leading region, top grossing product types, etc. It includes more of a qualitative information about the market.)
6.1. Market Size Forecast Market Size Forecast
6.1.1. By Value
6.2. Market Share Forecast Market Share Forecast
6.2.1. By Industry (Medical Devices v/s Pharmaceutical)
6.2.2. By Therapeutic Area (Oncology, Infectious Disease, Hematology, Cardiology, Dermatology, Neurology, Diabetes, Others)
6.2.5. By Company (2020)
6.2.6. By Region
6.3. Product Market Map Product Market Map
4
Table of Contents
S. No. Contents Contents Contents Contents Contents Page No.
7. Asia-Pacific In Silico Clinical Trials Market Outlook Asia-Pacific In Silico Clinical Trials Market Outlook Asia-Pacific In Silico Clinical Trials Market Outlook Asia-Pacific In Silico Clinical Trials Market Outlook Asia-Pacific In Silico Clinical Trials Market Outlook
7.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
7.1.1. By Value By Value By Value
7.2. Market Share Forecast Market Share Forecast Market Share Forecast
7.2.1. By Industry By Industry
7.2.2. By Therapeutic Area By Therapeutic Area By Therapeutic Area
7.2.3. By Country 7.2.3. By Country 7.2.3. By Country 7.2.3. By Country
7.3. Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis Asia-Pacific Country Analysis
7.3.1. China In Silico Clinical Trials Market Outlook China In Silico Clinical Trials Market Outlook China In Silico Clinical Trials Market Outlook
7.3.1.1. Market Size Forecast Market Size Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share Forecast Market Share Forecast
7.3.1.2.1. By Industry
7.3.1.2.2. By Therapeutic Area
7.3.2. India In Silico Clinical Trials Market Outlook India In Silico Clinical Trials Market Outlook India In Silico Clinical Trials Market Outlook
7.3.2.1. Market Size Forecast Market Size Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share Forecast Market Share Forecast
7.3.2.2.1. By Industry
7.3.2.2.2. By Therapeutic Area
5
Table of Contents
S. No. Contents Contents Contents Contents Contents Page No.
7.3.3. South Korea In Silico Clinical Trials Market Outlook South Korea In Silico Clinical Trials Market Outlook South Korea In Silico Clinical Trials Market Outlook
7.3.3.1. Market Size Forecast Market Size Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share Forecast Market Share Forecast
7.3.3.2.1. By Industry
7.3.3.2.2. By Therapeutic Area
7.3.4. Japan In Silico Clinical Trials Market Outlook Japan In Silico Clinical Trials Market Outlook Japan In Silico Clinical Trials Market Outlook
7.3.4.1. Market Size Forecast Market Size Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share Forecast Market Share Forecast
7.3.4.2.1. By Industry
7.3.4.2.2. By Therapeutic Area
7.3.5. Australia In Silico Clinical Trials Market Outlook Australia In Silico Clinical Trials Market Outlook Australia In Silico Clinical Trials Market Outlook
7.3.5.1. Market Size Forecast Market Size Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share Forecast Market Share Forecast
7.3.5.2.1. By Industry
7.3.5.2.2. By Therapeutic Area
6
Table of Contents
S. No. Contents Contents Contents Contents Contents Page No.
8. Europe In Silico Clinical Trials Market Outlook Europe In Silico Clinical Trials Market Outlook Europe In Silico Clinical Trials Market Outlook Europe In Silico Clinical Trials Market Outlook Europe In Silico Clinical Trials Market Outlook
8.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
8.1.1. By Value By Value By Value
8.2. Market Share Forecast Market Share Forecast Market Share Forecast
8.2.1. By Industry By Industry
8.2.2. By Therapeutic Area By Therapeutic Area By Therapeutic Area
8.2.3. By Country 8.2.3. By Country 8.2.3. By Country 8.2.3. By Country
8.3. Europe Country Analysis Europe Country Analysis Europe Country Analysis Europe Country Analysis
8.3.1. France In Silico Clinical Trials Market Outlook France In Silico Clinical Trials Market Outlook France In Silico Clinical Trials Market Outlook
8.3.1.1. Market Size Forecast Market Size Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share Forecast Market Share Forecast
8.3.1.2.1. By Industry
8.3.1.2.2. By Therapeutic Area
8.3.2. Germany In Silico Clinical Trials Market Outlook Germany In Silico Clinical Trials Market Outlook Germany In Silico Clinical Trials Market Outlook
8.3.2.1. Market Size Forecast Market Size Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share Forecast Market Share Forecast
8.3.2.2.1. By Industry
8.3.2.2.2. By Therapeutic Area
7
Table of Contents
S. No. Contents Contents Contents Contents Contents Page No.
8.3.3. United Kingdom In Silico Clinical Trials Market Outlook United Kingdom In Silico Clinical Trials Market Outlook United Kingdom In Silico Clinical Trials Market Outlook
8.3.3.1. Market Size Forecast Market Size Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share Forecast Market Share Forecast
8.3.3.2.1. By Industry
8.3.3.2.2. By Therapeutic Area
8.3.4. Italy In Silico Clinical Trials Market Outlook Italy In Silico Clinical Trials Market Outlook Italy In Silico Clinical Trials Market Outlook
8.3.4.1. Market Size Forecast Market Size Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share Forecast Market Share Forecast
8.3.4.2.1. By Industry
8.3.4.2.2. By Therapeutic Area
8.3.5. Spain In Silico Clinical Trials Market Outlook Spain In Silico Clinical Trials Market Outlook Spain In Silico Clinical Trials Market Outlook
8.3.5.1. Market Size Forecast Market Size Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share Forecast Market Share Forecast
8.3.5.2.1. By Industry
8.3.5.2.2. By Therapeutic Area
8
Table of Contents
S. No. Contents Contents Contents Contents Contents Page No.
9. North America In Silico Clinical Trials Market Outlook North America In Silico Clinical Trials Market Outlook North America In Silico Clinical Trials Market Outlook North America In Silico Clinical Trials Market Outlook North America In Silico Clinical Trials Market Outlook
9.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
9.1.1. By Value By Value By Value
9.2. Market Share Forecast Market Share Forecast Market Share Forecast
9.2.1. By Industry By Industry
9.2.2. By Therapeutic Area By Therapeutic Area By Therapeutic Area
9.2.3. By Country 9.2.3. By Country 9.2.3. By Country 9.2.3. By Country
9.3. North America Country Analysis North America Country Analysis North America Country Analysis North America Country Analysis
9.3.1. United States In Silico Clinical Trials Market Outlook United States In Silico Clinical Trials Market Outlook United States In Silico Clinical Trials Market Outlook
9.3.1.1. Market Size Forecast Market Size Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share Forecast Market Share Forecast
9.3.1.2.1. By Industry
9.3.1.2.2. By Therapeutic Area
9.3.2. Canada In Silico Clinical Trials Market Outlook Canada In Silico Clinical Trials Market Outlook Canada In Silico Clinical Trials Market Outlook
9.3.2.1. Market Size Forecast Market Size Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share Forecast Market Share Forecast
9.3.2.2.1. By Industry
9.3.2.2.2. By Therapeutic Area
9
Table of Contents
S. No. Contents Contents Contents Contents Contents Page No.
9.3.3. Mexico In Silico Clinical Trials Market Outlook Mexico In Silico Clinical Trials Market Outlook Mexico In Silico Clinical Trials Market Outlook
9.3.3.1. Market Size Forecast Market Size Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share Forecast Market Share Forecast
9.3.3.2.1. By Industry
9.3.3.2.2. By Therapeutic Area
10. South America In Silico Clinical Trials Market Outlook South America In Silico Clinical Trials Market Outlook South America In Silico Clinical Trials Market Outlook South America In Silico Clinical Trials Market Outlook South America In Silico Clinical Trials Market Outlook
10.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
10.1.1. By Value By Value By Value
10.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
10.2.1. By Industry By Industry
10.2.2. By Therapeutic Area By Therapeutic Area By Therapeutic Area
10.2.3. By Country 10.2.3. By Country 10.2.3. By Country 10.2.3. By Country
10.3. South America Country Analysis South America Country Analysis South America Country Analysis South America Country Analysis
10.3.1. Brazil In Silico Clinical Trials Market Outlook Brazil In Silico Clinical Trials Market Outlook Brazil In Silico Clinical Trials Market Outlook
10.3.1.1. Market Size Forecast Market Size Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share Forecast Market Share Forecast
10.3.1.2.1. By Industry
10.3.1.2.2. By Therapeutic Area
10
Table of Contents
S. No. Contents Contents Contents Contents Contents Page No.
10.3.2. Argentina In Silico Clinical Trials Market Outlook Argentina In Silico Clinical Trials Market Outlook Argentina In Silico Clinical Trials Market Outlook
10.3.2.1. Market Size Forecast Market Size Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share Forecast Market Share Forecast
10.3.2.2.1. By Industry
10.3.2.2.2. By Therapeutic Area
10.3.3. Colombia In Silico Clinical Trials Market Outlook Colombia In Silico Clinical Trials Market Outlook Colombia In Silico Clinical Trials Market Outlook
10.3.3.1. Market Size Forecast Market Size Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share Forecast Market Share Forecast
10.3.3.2.1. By Industry
10.3.3.2.2. By Therapeutic Area
11. Middle East and Africa In Silico Clinical Trials Market Outlook Middle East and Africa In Silico Clinical Trials Market Outlook Middle East and Africa In Silico Clinical Trials Market Outlook Middle East and Africa In Silico Clinical Trials Market Outlook Middle East and Africa In Silico Clinical Trials Market Outlook
11.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
11.1.1. By Value By Value By Value
11.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
11.2.1. By Industry By Industry
11.2.2. By Therapeutic Area By Therapeutic Area By Therapeutic Area
11.2.3. By Country 11.2.3. By Country 11.2.3. By Country 11.2.3. By Country
11.3. Middle East and Africa Country Analysis Middle East and Africa Country Analysis Middle East and Africa Country Analysis Middle East and Africa Country Analysis
11
Table of Contents
S. No. Contents Contents Contents Contents Contents Page No.
11.3.1. South Africa In Silico Clinical Trials Market Outlook South Africa In Silico Clinical Trials Market Outlook South Africa In Silico Clinical Trials Market Outlook
11.3.1.1. Market Size Forecast Market Size Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share Forecast Market Share Forecast
11.3.1.2.1. By Industry
11.3.1.2.2. By Therapeutic Area
11.3.2. Saudi Arabia In Silico Clinical Trials Market Outlook Saudi Arabia In Silico Clinical Trials Market Outlook Saudi Arabia In Silico Clinical Trials Market Outlook
11.3.2.1. Market Size Forecast Market Size Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share Forecast Market Share Forecast
11.3.2.2.1. By Industry
11.3.2.2.2. By Therapeutic Area
11.3.3. UAE In Silico Clinical Trials Market Outlook UAE In Silico Clinical Trials Market Outlook UAE In Silico Clinical Trials Market Outlook
11.3.3.1. Market Size Forecast Market Size Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share Forecast Market Share Forecast
11.3.3.2.1. By Industry
11.3.3.2.2. By Therapeutic Area
12

• Table of Contents

S. No. Contents Contents Contents Page No.
12. Market Dynamics Market Dynamics Market Dynamics
12.1. Drivers Drivers
12.2. Challenges Challenges
13. Market Trends Developments Market Trends Developments Market Trends Developments
14. Competitive Landscape Competitive Landscape Competitive Landscape
14.1. Competition Outlook Competition Outlook
14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled) Company Profiles (SWOT Analysis of Top 5 Players Profiled)
14.2.1. Company Details
14.2.2. Material Types Services
14.2.3. Financials (As Reported)
14.2.4. Key Market Focus Geographical Presence
14.2.5. Recent Developments
14.2.6. Key Management Personnel
15. Strategic Recommendations Strategic Recommendations Strategic Recommendations Strategic Recommendations
16. About Us Disclaimer About Us Disclaimer About Us Disclaimer About Us Disclaimer
13
RESEARCH METHODOLOGY
14

• Research Methodology

Market Profiling
Data Analysis
Data Collection
Data Validation
Developing List of Respondents
Formulating Questionnaire
In-depth secondary research was conducted to
determine top players in the global in silico
clinical trials market, overall market size and
segmental market size.
The data was scrutinized using MS-Excel,
statistical tools and internal proprietary
database to obtain qualitative and quantitative
insights about the global in silico clinical
trials market.
Data obtained as a result of primary and
secondary research was validated through rigorous
triangulation.
TechSci conducted interviews with industry
experts and industry players for data collection
and verification.
In order to conduct industry experts interviews,
TechSci formulated a detailed discussion guide.
List of industry players and industry specialists
was developed.
Primary Research
Desk Research
Company Analysis

• Recent Developments
• Market Changing Aspects/Dynamics
• Government Policies
• Conclusion

• Market Participants
• Key Strengths

• Identifying Key Opinion Leaders
• Questionnaire Design
• In-depth Interviews

15

• Research Methodology

• Baseline Methodology
• Our dedicated team of industry experts has
  monitored and analyzed various aspects of the
  global in silico clinical trials market. The team
  has analyzed the outlook of various segments of
  this market, while considering the major
  influencing factors such as in silico clinical
  trials. The study includes market forecasting,
  which would enable our clients to take better
  decisions while planning their strategy to
  achieve sustainability in the global in silico
  clinical trials market.
• Methodology Followed for Calculation of Market
  Size
• Market Size by Value Market size, in terms of
  value, for the year 2020 was calculated based on
  information collected through exhaustive
  secondary research and primary surveys, with
  various key opinion leaders/stakeholders, such as
  in silico clinical trials companies, channel
  partners, market influencers end-users,
  industry experts, and other industry
  participants.
• The team interviewed more than 15 20 in silico
  clinical trials companies, 100 120 end-users,
  and 15 20 industry experts and other value
  chain stakeholders in the global in silico
  clinical trials market to obtain the overall
  market size from 2016 to 2020, which was
  validated by the Delphi technique. Taking
  standard deviation into consideration, the market
  size was averaged out, to arrive at the market
  size data during 2016-2020.

16

• Research Methodology

• Respondents were asked about the current and
  future market growth rates, market shares by
  industry, by therapeutic area, by company and by
  region. Removing the outlier responses, the
  geometric mean of growth estimates and provider
  wise revenue shares generated across various
  segments were considered, to arrive at the final
  revenue shares. Revenue shares generated across
  various segments were further triangulated from
  other stakeholders.
• Methodology Followed for Calculation of Market
  Shares
• Market share by industry, by therapeutic area, by
  company and by region were calculated based on
  the responses received through primary surveys
  with industry experts, in which the respondents
  were asked about the market shares or revenue
  generated from various segments of in silico
  clinical trials markets. The final shares were
  calculated by taking the geometric mean of the
  responses gathered from key opinion leaders after
  eliminating the outliers.
• Methodology Followed for Forecasting
• TechSci Research performed periodical checks on
  data collected through the surveys with logic
  checks and analyzed the survey results in
  SPSS/Tableau Software.
• Data triangulation techniques were applied to
  fill the gaps and to present a more meaningful
  picture of the market. To forecast global in
  silico clinical trials market, TechSci Research
  used various forecast techniques such as
• Moving Average
• Time Series Analysis
• Regression Analysis
• Econometric and Judgmental Analysis

17

• Research Methodology

TechSci Research used its own forecast tool,
which is based on the growth of various allied
industries in respective regions. TechSci
Research also used the impact analysis during
short, medium and long term period to estimate
the demand and to reach accurate market numbers.
It should be noted that the figures compiled are
only for the organized market including market
share data. The currency used in the report is
the United States Dollar (USD), with the market
size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
Certara, Inc. Novadiscovery Sas Insilico Medicine, Inc. Dassault Systèmes SE GNS Healthcare Inc The AnyLogic Company InSilicoTrials Immunetrics Inc Nuventra Pharma Sciences Abzena Ltd World Bank TechSci Research Proprietary Database Knowledge Repository Company Annual Reports Industry Magazines Industry Reports News Dailies Credible Paid Databases
18

• Competitor Profile Certara, Inc.

According to TechSci Research report, Global In
Silico Clinical Trials Market By Industry
(Medical Devices v/s Pharmaceutical) By
Therapeutic Area (Oncology, Infectious Disease,
Hematology, Cardiology, Dermatology, Neurology,
Diabetes, Others) By Region, Competition Forecast
Opportunities, 2026, the global in silico
clinical trials market may potentially project an
impressive growth in the forecast period,
2022-2026, with an impressive CAGR on the account
of rapidly advancing technologies being
incorporated in the health care sector to evolve
patient care. Moreover, consistent research and
development of advanced drugs is aiding the
growth of the global in silico clinical trials
market in the upcoming five years. Technological
advancements like 3D imaging techniques,
artificial organ manufacturing, etc. is further
aiding the growth of the global in silico
clinical trials market in the next five years.
The advantages of in silico process are another
major growth factor for the market. The method
saves time, resources, and avoids the ethical
issues that often arises with animal and human
clinical trials. Also, with the growing economy
the industry suffers from the lack of human test
subjects and animal test subjects due to
decreasing population of animals, the in silico
clinical trials overcomes these setbacks and thus
supports the growth of the global in silico
clinical trials market in the future five years
of forecast. Also, Food and Drug Administration,
FDA is readily accepting the in silico clinical
trials and authorizing the pharmaceutical,
biotechnological institutes to commercialize
their recent drug development products and
medical devices for the benefits of the patients.
Though, the in silico clinical trials are not
very popular in smaller economies, the rapid
evolution and advancing technologies in the
healthcare industry worldwide is expected to
substantiate the growth of global in silico
clinical trials market. In silico clinical trials
are computer simulation method for the
developmental and regulatory evaluation of the
pharmaceutical or medical devices or therapies.
The method is not completely evolved currently
but a constant research and development affair
would benefit the future advancement and drug
discovery. The trial is often understood by the
involvement of computer system to restructure a
3D image of the organs and systems and then
applying the trial methods.  The global in silico
clinical trials market segmented is based on
industry, therapeutic area, competitional
landscape, and regional distribution. Based on
therapeutic area, the market is further
bifurcated into oncology, infectious disease,
hematology, cardiology, dermatology, neurology,
diabetes, and others. Oncology is expected to
dominate the market segment and generate maximum
revenue shares of the market in the next five
years. The growth can be attributed to rapid
application of in silico clinical trials for the
oncology cases. The cases of patients suffering
from various type of cancer and related studies
to over come the diseases and enhance the
treatment procedure the in silico clinical trials
are increasing and thus supporting the market
growth. Oncology is study of cancerous cells. In
silico clinical trials are incorporated for the
study of cancerous cells and to develop drugs
that can decrease the sizes and numbers of
cancerous cells and to understand the
functioning. Medical devices as well as drugs are
tested via in silico clinical trials and further
supporting the growth of global in silico
clinical trials market in the future five years.
Based on industry, the market is further divided
between medical devices, and pharmaceuticals.
Pharmaceutical sub-segment is anticipated to hold
the largest revenue shares of the market and
dominate the segment in the upcoming five years,
on the account of rapidly increasing instances of
drug development and thus conducted clinical
trials. Moreover, the concerns over harmful and
adverse effects of the newly developed drugs on
the animals and human lives being considered as
test subject is substantiating the growth of the
global in silico clinical trials market in the
next five years. Medical devices industry is also
benefitting and thus registering significant
growth in the future five years on the ground of
surging demands for the medically and
technologically advanced medical equipment and
devices for providing best possible diagnosis and
treatment to the population. Holding the major
shares of the global in silico clinical trials
market are Certara, Inc., Novadiscovery Sas,
Insilico Medicine, Inc., Dassault Systèmes SE,
GNS Healthcare Inc, The AnyLogic Company,
InSilicoTrials, Immunetrics Inc, Nuventra Pharma
Sciences, Abzena Ltd, among others. Market
players are actively involved in the research and
technological development in the advanced medical
device and pharmacological developments. The
advanced technology has made it possible for the
healthcare industry to provide excellent
healthcare services through in silico clinical
trials. Further advancement would aid the market
value and brand establishment in the future five
years. New market players may focus on the
research and development to provide options that
satisfies the consumer demand as well as benefits
the market players in building their brand value.
Other competitive strategies include mergers
acquisitions and new product developments. North
America supports the most evolved healthcare
industry and is a promising region for the future
growth of the global in silico clinical trials
market. With advancing technology and consistent
research, the market is anticipated to grow
further in next five years. United States and
Canada are major economies that has advancing and
evolving healthcare industry and services that
provides for the best possible diagnostic and
treatment processes. In silico clinical trials
are rapidly increasing in the region and new
market players must involve in research and
technological advancements, said Mr. Karan
Chechi, Research Director with TechSci Research,
a research based Global management consulting
firm.
19

• Competitor Profile Certara, Inc.

Global In Silico Clinical Trials Market Size, By
Value (USD Million), 2016-2026F
CAGR By Value
XX
North America In Silico Clinical Trials Market
Share, Industry, By Value, 20162026F
United States In Silico Clinical Trials Market
Share, By Therapeutic Area, By Value, 20162026F
20

• Competitor Profile Certara, Inc.

Report Name GLOBAL IN SILICO CLINICAL
TRIALS MARKET FORECAST OPPORTUNITIES 2016
2026
License Type Price
Single User License 4900
Multi-User License 5900
Custom Research License 8900
To View Sample OR Purchase Report  
21
About Us Disclaimer
TechSci Research is a global market research and
consulting company with offices in the US, UK and
India. TechSci Research provides market research
reports in number of areas to organizations. The
company uses innovative business Modes that focus
on improving productivity, while ensuring
creation of high-quality reports. The proprietary
forecasting Modes use various analyses of both
industry-specific and macroeconomic variables on
a state-by-state basis to produce a unique
bottom-up Mode of a country, regional and
global industry prospects. Combined with the
detailed analysis of company activity and
industry trends, the result is a uniquely rich
evaluation of the opportunities available in the
market.
Related Reports

• Organ-on-Chip Market - Global Industry Size,
  Share, Trends, Opportunity and Forecast,
  2016-2026 Segmented By Type (Liver, Heart, Lung,
  Kidney, Others), By Offering (Products v/s
  Services), By Material Type (Polymer, PDMS,
  Glass, Silicon, Others), By Application
  (Physiological Model Development, Drug Discovery,
  Toxicological Research, Molecular Biology,
  Others), By End User (Pharmaceutical
  Biotechnology Companies, Academic Research
  Institutes, Cosmetic Industry, Others), By Region
  2016-2026
• Middle East Africa Active Pharmaceutical
  Ingredient Market By Method of Synthesis
  (Biological v/s Synthetic) By Source (Contact
  Manufacturing Organizations v/s In-House
  Manufacturing) By Therapeutic Application
  (Cardiovascular Diseases, Anti-diabetic Drugs,
  Oncology Drugs, Neurological Disorders,
  Musculoskeletal Disorders, Others) By Molecule
  Type (Small v/s Large) By Potency (Low v/s High)
  By Drug Type (Innovator v/s Generics) By Country,
  Competition Forecast Opportunities, 2026

TechSci Research North America 708 Third
Avenue, Manhattan, New York, United States Tel
1- 646- 360- 1656 Email sales_at_techsciresearch.co
m www.techsciresearch.com
TechSci Research Europe 54, Old brook,
Bretton, Peterborough, United Kingdom Email
sales_at_techsciresearch.com www.techsciresearch.com
TechSci Research Asia-Pacific B 44, Sector
57, Noida, National Capital Region, U.P. -
India Tel [phone] Email
sales_at_techsciresearch.com www.techsciresearch.com
Disclaimer
The contents of this report are based on
information generally available to the public
from sources believed to be reliable. No
representation is made that it is timely,
accurate or complete. TechSci Research has taken
due care and caution in compilation of data as
this has been obtained from various sources
including which it considers reliable and
firsthand. However, TechSci Research does not
guarantee the accuracy, adequacy or completeness
of any information and it is not responsible for
any errors or omissions or for the results
obtained from the use of such information and
especially states that it has no financial
liability whatsoever to the subscribers / users
of this report. The information herein, together
with all estimates and forecasts, can change
without notice. All the figures provided in this
document are indicative of relative market size
and are strictly for clients internal
consumption. Usage of the same for purpose other
than internal will require prior approval of
TechSci Research.